Aripiprazole pharmacotherapy of borderline personality disorder: A series of three consecutive case reports

Pharmacopsychiatry

Volumn 39, Issue 3, 2006, Pages 111-112

  Mobascher, Arian ^a   Mobascher, J ^a   Schlemper, V ^a   Winterer, G ^a   Malevani, J ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CHLORAL HYDRATE; ETILEFRINE; PIPAMPERONE; QUETIAPINE;

ADULT; ANAMNESIS; ARTICLE; BORDERLINE STATE; CASE REPORT; CLINICAL FEATURE; DIZZINESS; DRUG EFFECT; FEMALE; HUMAN; NAUSEA; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RESTLESSNESS;

ADOLESCENT; ADULT; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; BORDERLINE PERSONALITY DISORDER; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTENSION, ORTHOSTATIC; PERSONALITY ASSESSMENT; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; QUINOLONES;

EID: 33745132142     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-941485     Document Type: Article

References (9)

1. American Psychiatric Association. Practice guidelines for the treatment of patients with borderline personality disorder. Am J Psychiatry 2001; 158: 1-52
2. Bohus M, Limberger MF, Frank U, Sender I, Gratwohl T, Stieglitz RD. Development of the borderline symptom list. Psychother Psychosom Med Psychol 2001; 51: 201-211
3. Bohus M, Frank U, Limberger MF, Zanarini M, Chapman A, Stieglitz RD. Psychometric Properties of the Borderline Symptom List (BSL). Psychpathology: in press,
4. Derogatis LR, Lipman RS, Covi L. SCL-90: An outpatient psychiatric rating scale - preliminary report. Psychopharmacology Bulletin 1973; 9: 13-28
5. Grootens KP and Verkes RJ. Emerging evidence for the use of atypical antipsychotics in borderline personality disorder. Pharmacopsychiatry 2005; 38: 20-23
6. Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry 1991; 48: 060-1064
7. Soler J, Pasqual JC, Campins J, Barrachina J, Puigdemont D, Alvarez E, Perez V. Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. Am J Psychiatry 2005; 162: 221-1224
8. Zanarini MC and Frankenburg FR. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 2001; 62: 849-854
9. Zanarini MC, Frankenburg FR, Parachini EA. A preliminary, randomized trial of fluoxetine, olanzapine and the olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry 2004; 65: 903-907